Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA9 | Q16790 | 2/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | TERT | O14746 | 3/20 | 0.39 |
| ▸ | PLK1 | P53350 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13784288 | 0.96 | TERT (0.41) | CA1CA2CA9CHRM5CA12 | |
| SCHEMBL12744278 | 0.89 | CYP1B1 (0.46) | CA1CA2CA9CA12CA4 | |
| SCHEMBL13784290 | 0.89 | CHRM5 (0.45) | CA1CA2CA9CHRM5CA12 | |
| SCHEMBL13784293 | 0.88 | CHRM5 (0.51) | CA1CA2CA9CHRM5CA12 | |
| SCHEMBL12744285 | 0.86 | CYP1B1 (0.46) | CA1CA2CA9CA12CA4 | |
| SCHEMBL13784284 | 0.85 | ALDH1A1 (0.55) | CA1CA2CA9CA12CA4 | |
| SCHEMBL13784294 | 0.84 | CHRM5 (0.50) | CA1CA2CA9CHRM5CA12 | |
| SCHEMBL13784286 | 0.81 | ALDH1A1 (0.53) | CA1CA2CA9CA12CYP1B1 | |
| SCHEMBL13784710 | 0.81 | CHRM5 (0.46) | CA1CA2CA9CHRM5CA12 | |
| SCHEMBL12744286 | 0.78 | CHRM5 (0.50) | CA1CA2CA9CHRM5CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8350035-B2 | Fluorinated rylenetetracarboxylic acid derivatives and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-01-08 | — | — | US | disclosed |
| US-8350035-B2 | Fluorinated rylenetetracarboxylic acid derivatives and use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2013-01-08 | — | — | US | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| WO-2007093643-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF SE (DE) | 2007-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | FXR2, FXR1, FTO | CA1 143/4885CA2 1294/4885CA9 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.